0001140361-23-031424.txt : 20230628 0001140361-23-031424.hdr.sgml : 20230628 20230628160202 ACCESSION NUMBER: 0001140361-23-031424 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20230626 DATE AS OF CHANGE: 20230628 EFFECTIVENESS DATE: 20230626 FILER: COMPANY DATA: COMPANY CONFORMED NAME: METLIFE INC CENTRAL INDEX KEY: 0001099219 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 134075851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: 1934 Act SEC FILE NUMBER: 028-18621 FILM NUMBER: 231052084 BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 212-578-5500 MAIL ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 13F-HR/A 1 primary_doc.xml X0202 13F-HR/A LIVE 0001099219 XXXXXXXX 06-30-2020 06-30-2020 true 2 NEW HOLDINGS METLIFE INC
200 PARK AVENUE NEW YORK NY 10166
13F COMBINATION REPORT 028-18621 0000931588 028-16107 PROVIDA PENSION FUND ADMINISTRATOR 0000728618 028-00491 METROPOLITAN LIFE INSURANCE CO/NY 0001529735 028-18628 000142463 801-67314 MetLife Investment Management, LLC Y This amendment adds a new holdings entry of security that was inadvertently omitted in the 13F Combination Report filed for this quarter, as amended by the 13F amendment filed on June 26, 2023. MetLife, Inc. is the parent holding company of certain institutional investment managers. For purposes of the reporting requirements under Section 13(f) of the Securities Exchange Act of 1934 (the Act), and the rules promulgated thereunder, MetLife, Inc. itself does not exercise, and therefore disclaims, investment discretion with respect to any Section 13(f) securities positions over which its investment operating subsidiaries exercise such discretion. To the extent, however, that MetLife Inc.'s ownership interest in such subsidiaries may nevertheless give rise to a Form 13F obligation on behalf of MetLife, Inc., the information required by Form 13F is reported herein on behalf of all such subsidiaries.
Steven Goulart EVP & Chief Investment Officer 973-355-4814 /s/ Steven Goulart WHIPPANY NJ 06-26-2023 0 1 11399959
INFORMATION TABLE 2 informationtable.xml CELLCOM ISRAEL LTD SHS M2196U109 11399959 196385 SH DFND 0 196385 0